Impact of Nutritional Counselling in Children With Autism
NCT ID: NCT04652388
Last Updated: 2020-12-03
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
UNKNOWN
NA
20 participants
INTERVENTIONAL
2020-09-01
2022-09-01
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
OTHER
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Nutritional counseling
Children with autism spectrum disorders to whom administer nutritional counseling
Nutritional counseling
Nutritional counseling about mediterranean diet
Controls
No intervention
No interventions assigned to this group
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Nutritional counseling
Nutritional counseling about mediterranean diet
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
Exclusion Criteria
* Concomitant presence of other chronic diseases
* epilepsy,
* neurological syndromes,
* immunodeficiencies,
* diabetes,
* congenital heart disease,
* autoimmune diseases,
* inborn errors of metabolism,
* tuberculosis,
* cystic fibrosis,
* chronic respiratory tract diseases,
* inflammatory bowel disease,
* celiac disease,
* eosinophilic pathologies of the gastrointestinal tract,
* functional gastrointestinal disorders,
* obesity,
* tumors,
* malnutrition • Major malformations or previous surgery of the gastrointestinal / urinary / respiratory tract.
24 Months
48 Months
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Federico II University
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Roberto Berni Canani
Chief of the Pediatric Allergy Program at the Department of Translational Medical Science Chief of the ImmunoNutritionLab at CEINGE - Advanced Biotechnologies
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
University of Naples Federico II
Naples, , Italy
Countries
Review the countries where the study has at least one active or historical site.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
Roberto Berni Canani
Role: primary
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
353/20
Identifier Type: -
Identifier Source: org_study_id